The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of patients with node-negative (N0), triple-negative breast cancer (TNBC) who did not receive adjuvant chemotherapy according to stromal TILs (sTILs).
 
Roberto Antonio Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst)
 
Jodi M Carter
No Relationships to Disclose
 
David W. Hillman
No Relationships to Disclose
 
Kathleen S. Tenner
No Relationships to Disclose
 
David Zahrieh
No Relationships to Disclose
 
Minetta C. Liu
Research Funding - Eisai (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Ionis Pharmaceuticals (Inst); Menarini Silicon Biosystems; Merck; Pfizer
 
James N. Ingle
No Relationships to Disclose
 
Krishna R. Kalari
No Relationships to Disclose
 
Daniel W. Visscher
No Relationships to Disclose
 
Judy Caroline Boughey
Honoraria - UpToDate
Consulting or Advisory Role - CairnSurgical
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Fergus Couch
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Ambry Genetics; Qiagen
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL; Qiagen
Other Relationship - Ambry Genetics
 
Matthew P. Goetz
Consulting or Advisory Role - bioTheranostics; Biovica; Context Therapeutics; Eisai; Genomic Health; Lilly; Novartis; Pfizer; Sermonix Pharmaceuticals
Research Funding - Lilly (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly